• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

参附注射液治疗脓毒症的有效性和安全性的系统评价和 Meta 分析方案。

Efficacy and safety of Shenfu injection in the treatment of sepsis: A protocol for systematic review and meta-analysis.

机构信息

Emergency Department, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, China.

General Medical Department, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province, China.

出版信息

Medicine (Baltimore). 2021 Sep 17;100(37):e27196. doi: 10.1097/MD.0000000000027196.

DOI:10.1097/MD.0000000000027196
PMID:34664847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8448001/
Abstract

BACKGROUND

Sepsis is a syndrome of infection-induced systemic inflammatory response. Conventional treatment combined with Shenfu injection (SFI) has been previously validated clinical effective in alleviating inflammatory response in patients with septic shock. However, evidence-based medical evidence is scant. Herein, we designed the protocol of a proposed study based on the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines, aiming to systematically evaluate the efficacy and safety of SFI in patients with sepsis.

METHODS

Eligible studies reporting the efficacy and safety of SFI in the treatment of sepsis published before August 2021 will be searched from online databases, including the PubMed, Web of Science, EMBASE, Ovid, the Cochrane Library, Wanfang Database, China National Knowledge Infrastructure, and China Biology Medicine Disc. The literature selection process will be reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines. After data extraction and methodological quality evaluation, Stata 12.0 software will be used to synthesize the data through fixed/random effects of meta-analysis models.

RESULTS

The results of this meta-analysis will be submitted to a peer-reviewed journal for publication.

CONCLUSION

This study will provide reliable evidence-based basis for the clinical application of SFI in the treatment of sepsis.

OSF REGISTRATION NUMBER

DOI 10.17605/OSF.IO/KCMDQ.

摘要

背景

败血症是一种感染引起的全身炎症反应综合征。常规治疗联合参附注射液(SFI)已被证实可有效缓解感染性休克患者的炎症反应。然而,目前缺乏循证医学证据。本研究旨在基于系统评价和荟萃分析的首选报告项目指南制定研究方案,以系统评价 SFI 治疗败血症患者的疗效和安全性。

方法

我们将检索 2021 年 8 月前发表的关于 SFI 治疗败血症的疗效和安全性的研究,检索数据库包括 PubMed、Web of Science、EMBASE、Ovid、Cochrane 图书馆、万方数据库、中国知网和中国生物医学文献数据库。文献筛选过程将按照系统评价和荟萃分析的首选报告项目指南进行报告。提取数据和评价方法学质量后,采用 Stata 12.0 软件通过固定/随机效应模型进行荟萃分析。

结果

本荟萃分析的结果将提交给同行评议期刊发表。

结论

本研究将为 SFI 治疗败血症的临床应用提供可靠的循证医学依据。

OSF 注册号:DOI 10.17605/OSF.IO/KCMDQ。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0613/8448001/57e1de55b7a2/medi-100-e27196-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0613/8448001/57e1de55b7a2/medi-100-e27196-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0613/8448001/57e1de55b7a2/medi-100-e27196-g001.jpg

相似文献

1
Efficacy and safety of Shenfu injection in the treatment of sepsis: A protocol for systematic review and meta-analysis.参附注射液治疗脓毒症的有效性和安全性的系统评价和 Meta 分析方案。
Medicine (Baltimore). 2021 Sep 17;100(37):e27196. doi: 10.1097/MD.0000000000027196.
2
Efficacy and safety of Shenfu injection for patients with return of spontaneous circulation after sudden cardiac arrest: Protocol for a systematic review and meta-analysis.参附注射液对心脏骤停后自主循环恢复患者的疗效及安全性:一项系统评价与Meta分析方案
Medicine (Baltimore). 2018 Sep;97(38):e12500. doi: 10.1097/MD.0000000000012500.
3
Shenfu injection alleviates the clinical symptoms of heart failure patients combined with conventional treatment: A protocol for systematic review and meta-analysis of randomized clinical trials.参附注射液联合常规疗法治疗心力衰竭患者的临床症状的疗效:系统评价和随机临床试验的荟萃分析方案。
Medicine (Baltimore). 2021 Apr 16;100(15):e23736. doi: 10.1097/MD.0000000000023736.
4
Guominjian for allergic rhinitis: A protocol for systematic review and meta-analysis of randomized clinical trials.过敏性鼻炎的“国民健”:一项随机临床试验系统评价与Meta分析方案
Medicine (Baltimore). 2020 Oct 30;99(44):e22854. doi: 10.1097/MD.0000000000022854.
5
Efficacy and safety of Shenqi Fuzheng injection combined with platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A protocol for systematic review and meta-analysis of randomized controlled trials.参芪扶正注射液联合铂类化疗治疗Ⅲ/Ⅳ期非小细胞肺癌的疗效与安全性:一项随机对照试验的系统评价与Meta分析方案
Medicine (Baltimore). 2019 Sep;98(39):e17350. doi: 10.1097/MD.0000000000017350.
6
Efficacy and safety of Buzhong Yiqi decoction combined with western medicine in the treatment of myasthenia gravis: A protocol for systematic review and meta-analysis.补中益气汤联合西药治疗重症肌无力的疗效及安全性的系统评价和 Meta 分析方案。
Medicine (Baltimore). 2021 Mar 19;100(11):e24807. doi: 10.1097/MD.0000000000024807.
7
Shaofu Zhuyu decoction for primary dysmenorrhea: A protocol for systematic review and meta-analysis.少腹逐瘀汤治疗原发性痛经:系统评价和荟萃分析方案。
Medicine (Baltimore). 2021 Jun 11;100(23):e26226. doi: 10.1097/MD.0000000000026226.
8
Shenfu injection for heart failure based on the AMSTAR-2, PRISMA, and GRADE tools.参附注射液治疗心力衰竭的 AMSTAR-2、PRISMA 和 GRADE 工具评价。
Ann Palliat Med. 2021 Jun;10(6):6535-6555. doi: 10.21037/apm-21-1073. Epub 2021 Jun 15.
9
The efficacy and safety of Chinese herbal compound in pediatric patients with allergic rhinitis: A protocol for systematic review and meta-analysis.中药复方治疗小儿过敏性鼻炎的疗效与安全性:系统评价与Meta分析方案
Medicine (Baltimore). 2020 Aug 7;99(32):e21643. doi: 10.1097/MD.0000000000021643.
10
Effectiveness and safety of Guilu Erxian Glue (a traditional Chinese medicinal product) for the treatment of postmenopausal osteoporosis: A protocol for systematic review and meta-analysis.龟鹿二仙胶(一种传统中药产品)治疗绝经后骨质疏松症的有效性和安全性:系统评价与荟萃分析方案
Medicine (Baltimore). 2020 Jul 17;99(29):e20773. doi: 10.1097/MD.0000000000020773.

引用本文的文献

1
Shenfu injection promotes self-renewal of intestinal stem cells in sepsis-induced intestinal injury via inducing ATF4 expression.参附注射液通过诱导ATF4表达促进脓毒症诱导的肠损伤中肠干细胞的自我更新。
Front Pharmacol. 2025 Jul 31;16:1500157. doi: 10.3389/fphar.2025.1500157. eCollection 2025.
2
A Direct Relationship Between 'Blood Stasis' and Fibrinaloid Microclots in Chronic, Inflammatory, and Vascular Diseases, and Some Traditional Natural Products Approaches to Treatment.慢性炎症性和血管性疾病中“血瘀”与类纤维蛋白微血栓的直接关系及一些传统天然产物治疗方法
Pharmaceuticals (Basel). 2025 May 12;18(5):712. doi: 10.3390/ph18050712.
3

本文引用的文献

1
Delays in Administration of the Second Antibiotic Dose in Patients With Severe Sepsis and Septic Shock.重症脓毒症和脓毒性休克患者第二次抗生素给药的延迟情况。
Hosp Pharm. 2021 Aug;56(4):247-251. doi: 10.1177/0018578719889025. Epub 2019 Nov 19.
2
Effects of comprehensive nursing on negative emotion and prognosis of patients with sepsis.综合护理对脓毒症患者负性情绪及预后的影响
Am J Transl Res. 2021 Jul 15;13(7):8221-8227. eCollection 2021.
3
Steroid, ascorbic acid, and thiamine in adults with sepsis and septic shock: a systematic review and component network meta-analysis.
Shenfu injection: a review of pharmacological effects on cardiovascular diseases.
参附注射液:对心血管疾病药理作用的综述
Front Pharmacol. 2024 Feb 14;15:1279584. doi: 10.3389/fphar.2024.1279584. eCollection 2024.
4
Shenfu injection as treatment for critical illness: a narrative review of clinical trials.参附注射液治疗危重症:临床试验的叙述性综述
J Thorac Dis. 2024 Jan 30;16(1):661-670. doi: 10.21037/jtd-23-105. Epub 2024 Jan 29.
5
Therapeutic Mechanism and Key Active Ingredients of Shenfu Injection in Sepsis: A Network Pharmacology and Molecular Docking Approach.参附注射液治疗脓毒症的作用机制及关键活性成分:基于网络药理学和分子对接的研究方法
Evid Based Complement Alternat Med. 2022 Aug 26;2022:9686149. doi: 10.1155/2022/9686149. eCollection 2022.
类固醇、抗坏血酸和硫胺素在脓毒症和脓毒性休克成人患者中的应用:一项系统评价和成分网络荟萃分析。
Sci Rep. 2021 Aug 4;11(1):15777. doi: 10.1038/s41598-021-95386-9.
4
Resuscitation fluid types in sepsis, surgical, and trauma patients: a systematic review and sequential network meta-analyses.脓毒症、外科和创伤患者的复苏液类型:系统评价和序贯网络荟萃分析。
Crit Care. 2020 Dec 14;24(1):693. doi: 10.1186/s13054-020-03419-y.
5
Effect of Extracorporeal Blood Purification on Mortality in Sepsis: A Meta-Analysis and Trial Sequential Analysis.体外血液净化对脓毒症死亡率的影响:一项荟萃分析和试验序贯分析
Blood Purif. 2021;50(4-5):462-472. doi: 10.1159/000510982. Epub 2020 Oct 28.
6
Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis.医院和 ICU 治疗的脓毒症的发病率和死亡率:一项更新和扩展的系统评价和荟萃分析的结果。
Intensive Care Med. 2020 Aug;46(8):1552-1562. doi: 10.1007/s00134-020-06151-x. Epub 2020 Jun 22.
7
Prediction of sepsis mortality using metabolite biomarkers in the blood: a meta-analysis of death-related pathways and prospective validation.基于血液代谢生物标志物预测脓毒症死亡率:死亡相关通路的荟萃分析和前瞻性验证。
BMC Med. 2020 Apr 15;18(1):83. doi: 10.1186/s12916-020-01546-5.
8
[Effect of traditional Chinese medicine syndrome differentiation and standard bundle therapy in patients with septic shock].[中医辨证与规范集束化治疗在感染性休克患者中的疗效]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Jul;31(7):852-856. doi: 10.3760/cma.j.issn.2095-4352.2019.07.011.
9
[Study on the levels of main inflammatory factors in septic shock and their clinical significance].[脓毒性休克主要炎症因子水平及其临床意义的研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Jun;31(6):680-683. doi: 10.3760/cma.j.issn.2095-4352.2019.06.004.
10
Sepsis: recognition, diagnosis and early management: © NICE (2017) Sepsis: recognition, diagnosis and early management.脓毒症:识别、诊断与早期管理:© 英国国家卫生与临床优化研究所(2017年)脓毒症:识别、诊断与早期管理
BJU Int. 2018 Apr;121(4):497-514. doi: 10.1111/bju.14179.